After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRSP belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of CRISPR Therapeutics AG is $5.29B. A total of 2.38 million shares were traded on the day, compared to an average of 2.04M shares.
In the most recent transaction, Kulkarni Samarth sold 60,000 shares of CRSP for 60.23 per share on Jan 22 ’26. After the transaction, the Chief Executive Officer now owns 134,201 company shares. In a previous transaction on Jan 20 ’26, Kulkarni Samarth sold 30,000 shares at 51.75 per share. CRSP shares that Chief Executive Officer owns now total 194,201.
Among the insiders who bought shares, Samarth Kulkarni acquired of 60,000 shares on Jan 22 ’26 at a per-share price of $60.81. In another insider transaction, RAJU PRASAD bought 34,972 shares at $60.19 per share on Jan 22 ’26.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRSP has a high of $78.48 and a low of $30.04.
As of this writing, CRSP has an earnings estimate of -$1.23 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of -$0.98 per share and a lower estimate of -$1.67. The company reported an EPS of -$0.44 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $20.41, while its Total Shareholder’s Equity was $2.40B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
